Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

A randomized, double-blind, placebo-controlled clinical trial of once-daily inhaled molgramostim nebulizer solution in adult subjects with autoimmune pulmonary alveolar proteinosis (aPAP) (IRB 262319)


Collapse Overview 
Collapse sponsor award id
SAV006


Collapse Biography 

Collapse Time 
Collapse start date
2021-07-27

Collapse end date
2031-07-26